Predictors of outcomes after PCI with incomplete revascularization: Impact of CTO and LAD vessel

Author:

Kuno Toshiki123ORCID,Weisz Giora4,Généreux Philippe5ORCID,Claessen Bimmer E.6ORCID,Shechter Michael7,Alexander Karen P.8,James Stefan K.9,Ohman E. Magnus8,Dressler Ovidiu10,Mehran Roxana1ORCID,Ben‐Yehuda Ori11,Stone Gregg W.1

Affiliation:

1. The Zena and Michael A. Wiener Cardiovascular Institute Icahn School of Medicine at Mount Sinai New York New York USA

2. Department of Medicine Mount Sinai Beth Israel Hospital New York New York USA

3. Division of Cardiology Montefiore Medical Center Bronx New York USA

4. Division of Cardiology Columbia University Medical Center, NewYork Presbyterian Hospital New York New York USA

5. Gagnon Cardiovascular Institute Morristown Medical Center Morristown New Jersey USA

6. Department of Cardiology, Heart Center Amsterdam UMC, University of Amsterdam Amsterdam the Netherlands

7. The Leviev Cardiothoracic & Vascular Center Sheba Medical Center Tel Hashomer Israel

8. Duke Clinical Research Institute Durham North Carolina USA

9. Department of Medical Sciences and Uppsala Clinical Research Center Uppsala University Uppsala Sweden

10. Cardiovascular Research Foundation New York New York USA

11. Sulpizio Cardiovascular Institute University of California San Diego San Diego California USA

Abstract

AbstractBackgroundIncomplete revascularization (ICR) after percutaneous coronary intervention (PCI) is associated with mortality and morbidity.AimWe sought to investigate whether ICR in the left anterior descending artery (LAD) is worse than ICR of the right coronary artery (RCA) or left circumflex artery (LCX); and whether ICR in patients with a chronic total occlusion (CTO) is worse than in those without.MethodsIn the RIVER‐PCI trial, 2651 patients with ICR after PCI were randomly assigned to ranolazine or placebo. Angiograms were assessed at an independent core laboratory in 2501 patients (94.3%). The primary endpoint was the composite of ischemia‐driven revascularization or hospitalization.ResultsA total of 1664 patients (66.5%) had ICR involving the LAD, whereas 837 (33.5%) had ICR limited to the RCA or LCX. At median follow‐up of 643 days, the primary endpoint occurred in 26.9% versus 26.5% of patients (adjusted HR [aHR]: 1.03, 95% confidence interval [CI]: 0.88–1.21). A nonrecanalized CTO was present in 854 patients (34.1%) with ICR after PCI. The primary endpoint occurred in 28.6% versus 25.9% of ICR patients with versus without a CTO (aHR: 1.10, 95% CI: 0.94–1.29). However, patients with a CTO had higher rates of ischemia‐driven hospitalization without revascularization (aHR: 1.27, 95% CI: 1.04–1.56), heart failure hospitalization (aHR: 2.69, 95% CI: 1.61–4.59) and myocardial infarction (aHR: 1.46, 95% CI: 1.11–1.92) compared with those without.ConclusionsThe 2‐year prognosis was similar in post‐PCI patients with ICR whether the LAD was versus was not involved. ICR patients with a CTO had more frequent hospitalizations for ischemia and myocardial infarctions compared with those without.

Publisher

Wiley

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3